TGFB1 and Hepatic fibrosis: In summary, carvedilol plays a preventive role in a dose-dependent fashion in the progression of hepatic fibrosis induced by BDL, which is associated with decreased TGF-β1 expression, increased HSCs apoptosis, and increased ratio of MMPs/TIMPs, as well as its antioxidant property.